“We are incredibly proud to introduce the only Health Canada-approved treatment for FA ... Canada approves Biogen’s Skyclarys ...

Lexeo Therapeutics’ gene therapy provides a healthy version of the frataxin gene, which is critical for energy production in ...

Stifel analysts said that Lexeo’s data showing reduced size and thickness of the heart’s left ventricle are “supportive of a drug effect” for the company’s gene therapy in Friedreich’s ataxia ...

Lexeo Therapeutics has posted updated data in Friedreich ataxia (FA) patients, linking a gene therapy to improvements on ...

Friedreich’s ataxia (FA) is a neurodegenerative disease most people have never heard of, and it remains widely misunderstood —and for the hundreds of Canadians who live with it, the lack of ...

Considering taking supplements to treat friedreich ataxia? Below is a list of common natural remedies used to treat or reduce the symptoms of friedreich ataxia. Follow the links to read common ...

Lexeo Therapeutics (LXEO) announced positive interim data across all dose cohorts of LX2006 for the treatment of Friedreich ataxia ...

That designation underscores a critical unmet need for Friedreich's ataxia, a rare neurodegenerative disorder without approved treatments for children. With approval, vatiquinone could set a new ...

A West Annapolis family has turned two life-altering diagnoses into more than $1 million for research toward finding a cure ...

Treatment with a 150 mg daily oral dose of omaveloxolone over 48 weeks in the study resulted in a significant improvement in the symptoms of Friedreich’s ataxia – measured using the mFARS ...

Lexeo Therapeutics announces positive interim phase 1/2 data for LX2006 in Friedreich ataxia cardiomyopathy: New York Wednesday, April 9, 2025, 12:00 Hrs [IST] Lexeo Therapeutics, ...